Stephen A. Sherwin
Independent Non-Executive Director
Company leadership profile.

Innovent Biologics, Inc., a biopharmaceutical company, engages in the research and development...
Innovent Biologics, Inc., a biopharmaceutical company, engages in the research and development of antibody and protein medicine products in the People’s Republic of China, the United States, Europe, and internationally. The company discovers, develops, manufactures, and commercializes monoclonal antibodies and other drugs for the treatment of oncology, ophthalmology, autoimmune, cardiovascular, and metabolic diseases. Its commercial stage product portfolio includes TYVYT (sintilimab injection), BYVASDA (bevacizumab injection), SULINNO (adalimumab injection), HALPRYZA (rituximab injection), PEMAZYRE (pemigatinib), olverembatinib, Cyramza (ramucirumab), Retsevmo (selpercatinib), FUCASO (Equecabtagene Autoleucel), SINTBILO (tafolecimab injection), DUPERT (fulzerasib), DOVBLERON (taletrectinib adipate), Jaypirca (pirtobrutinib), limertinib, SYCUME (teprotumumab N01 injection), mazdutide, PECONDLE (picankibart injection), and TABOSUN(Ipilimumab N01 injection). In addition, it sells and distributes pharmaceutical products; and offers consultation and research and development services. The company was incorporated in 2011 and is headquartered in Suzhou, the People’s Republic of China.
Listing identities only. Orbitrum does not publish live prices or market performance on this public profile.
Independent Non-Executive Director
Company leadership profile.
Co-Founder, Chairman & CEO
Company leadership profile.
Executive Director & Fund Managing Partner
Company leadership profile.
Chief Commercial Officer, General Manager & Executive Director
Company leadership profile.
Lead Independent Non-Executive Director
Company leadership profile.
Independent Non-Executive Director
Company leadership profile.
Member of CMC Strategic Advisory Board & Independent Non-Executive Director
Company leadership profile.
Independent Non-Executive Director
Company leadership profile.
Independent Non-Executive Director
Company leadership profile.
1 expert evaluated Innovent Biologics.
Explore the public profiles of experts who have evaluated this project.
Orbitrum Academy